Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Recombinant DNA Technology Market Size From 2025 to 2034?

In recent years, the recombinant DNA technology market has experienced substantial growth. Its size is predicted to increase from $858.94 billion in 2024 to $913.42 billion in 2025, an annual compound growth rate (CAGR) of 6.3%. The growth in the previous period is linked to healthcare needs, expansion in the biopharmaceutical industry, increased R&D investment, and the emergence of personalized medicine.

Projected robust expansion is to be observed in the recombinant DNA technology market over the upcoming years. The market is set to reach $1299.96 billion by 2029, scaled by a Compound Annual Growth Rate (CAGR) of 9.2%. Growth during this period can be chiefly traced back to the prevalence of chronic diseases, the surface of new biotech firms, an uptick in funding for biotech, the globalisation of biotech markets along with consumer approval and wide-scale awareness. Greater scientific progress, advancements in gene editing, cell and gene therapies, the forthcoming of RNA therapeutics and potential applications in rare disease treatment, in combination with the incorporation of AI and data, are key trends expected within the forecast period.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp

What Are the Core Market Drivers Propelling Growth in the Recombinant DNA Technology Industry?

The escalation in chronic illnesses is projected to spur the expansion of the recombinant DNA technology market. These chronic diseases, characterized as afflictions persisting for over a year, require ongoing medical attention, limit daily routines, or both. The advancement of healthcare through recombinant DNA technology involves the production of bio-pharmaceutical proteins utilized in medications and the substitution of unhealthy genes with healthy ones via gene therapy, aiming for disease eradication. For example, as per the World Health Organization, an intergovernmental organization based in Switzerland, by 2050, there would be an estimated 35 million new cancer cases, a 77% rise from the projected 20 million cases in 2022. Hence, the surge in chronic diseases is contributing to the growth of the recombinant DNA technology market.

How Is the Recombinant DNA Technology Market Segmented?

The recombinant dna technologymarket covered in this report is segmented –

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing

2) By Component Type: Expression System, Cloning Vector

3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

Subsegments:

1) By Recombinant Protein Drugs: Hormones, Growth Factors

2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines

3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop

4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems

5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies

6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8233&type=smp

Which Regions Are Driving the Next Phase of the Recombinant DNA Technology Market Growth?

North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Recombinant DNA Technology Industry?

Technological progression plays a significant role in the recombinant DNA technology market trend. The leading firms in this market are concentrating on state-of-the-art technologies to maintain their market status. For example, in August 2022, Bluebird bio, Inc., a biotechnological firm based in the U.S., introduced the ZYNTEGLO, a gene treatment approved by the U.S. Food and Drug Administration (FDA). This one-time therapy targets the genetic cause of beta-thalassemia, giving patients the opportunity to liberate themselves from consistent red blood cell transfusions. Using an ex-vivo lentiviral vector, it alters patient cells and is the first gene therapy for this condition to receive FDA approval in the U.S. This significant development has reduced the ongoing task of managing beta-thalassemia.

View the full report here:

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

How Is the Recombinant DNA Technology Market Defined and What Are Its Core Parameters?

Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8233

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model